Office Action Predictor
Last updated: April 16, 2026

Virogin Biotech Canada LTD

1 pending office actions

Portfolio Summary

1
Total Pending OAs
1
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18305366 HSV VECTORS WITH ENHANCED REPLICATION IN CANCER CELLS HILL, KEVIN KAI 1638 Final Rejection Apr 23, 2023

Managing Virogin Biotech Canada LTD's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in for Full Analysis

Enter your email to receive a magic link. No password needed.

Free tier: 3 strategy analyses per month